Index
RUT
P/E
-
EPS (ttm)
-1.83
Insider Own
3.87%
Shs Outstand
56.90M
Perf Week
5.70%
Market Cap
1.58B
Forward P/E
-
EPS next Y
-0.92
Insider Trans
22.39%
Shs Float
54.72M
Perf Month
12.22%
Enterprise Value
1.42B
PEG
-
EPS next Q
-0.46
Inst Own
99.49%
Perf Quarter
14.91%
Income
-102.47M
P/S
4.92
EPS this Y
11.08%
Inst Trans
4.51%
Perf Half Y
-16.12%
Sales
322.02M
P/B
4.55
EPS next Y
40.00%
ROA
-20.36%
Perf YTD
-11.54%
Book/sh
6.11
P/C
6.45
EPS next 5Y
28.31%
ROE
-27.81%
52W High
66.85 -58.37%
Perf Year
-57.22%
Cash/sh
4.32
P/FCF
-
EPS past 3/5Y
4.30% -7.02%
ROIC
-24.21%
52W Low
19.35 43.82%
Perf 3Y
-11.73%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
60.14% 109.04%
Gross Margin
62.98%
Volatility
5.64% 6.51%
Perf 5Y
-
Dividend TTM
-
EV/Sales
4.40
EPS Y/Y TTM
-7.59%
Oper. Margin
-33.86%
ATR (14)
1.60
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
5.51
Sales Y/Y TTM
29.26%
Profit Margin
-31.82%
RSI (14)
55.63
Dividend Gr. 3/5Y
- -
Current Ratio
6.73
EPS Q/Q
-24.31%
SMA20
3.09%
Beta
0.84
Payout
-
Debt/Eq
0.22
Sales Q/Q
20.20%
SMA50
9.13%
Rel Volume
0.71
Prev Close
27.00
Employees
888
LT Debt/Eq
0.22
SMA200
-9.27%
Avg Volume
1.48M
Price
27.83
IPO
Sep 15, 2021
Option/Short
Yes / Yes
Trades
Volume
1,058,731
Change
3.07%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-26 Initiated Robert W. Baird
Neutral
$30
Feb-26-26 Downgrade Oppenheimer
Outperform → Perform
Feb-26-26 Downgrade BofA Securities
Neutral → Underperform
$20
Dec-12-25 Initiated UBS
Buy
$62
Dec-08-25 Downgrade BofA Securities
Buy → Neutral
$38
Sep-02-25 Upgrade Oppenheimer
Perform → Outperform
$60
Jul-09-25 Initiated Stephens
Overweight
$70
Jul-07-25 Initiated Oppenheimer
Perform
Dec-02-24 Initiated Morgan Stanley
Overweight
$105
Nov-14-24 Initiated Jefferies
Hold
$95
Aug-11-23 Initiated Piper Sandler
Overweight
$42
May-31-23 Initiated William Blair
Outperform
Oct-31-22 Initiated BTIG Research
Neutral
Oct-25-22 Initiated Truist
Buy
$58
Sep-02-22 Initiated Wells Fargo
Overweight
$49
Jul-15-22 Initiated KeyBanc Capital Markets
Overweight
$47
Jun-23-22 Initiated B. Riley Securities
Buy
$53
Oct-11-21 Initiated SVB Leerink
Outperform
$46
Oct-11-21 Initiated Guggenheim
Buy
$45
Oct-11-21 Initiated Goldman
Neutral
$37
Show Previous Ratings
May-28-26 08:00AM
May-14-26 08:00AM
Apr-30-26 04:03PM
08:30AM
03:17AM
04:03PM
Loading…
Apr-29-26 04:03PM
Apr-28-26 09:24AM
Apr-09-26 04:05PM
Mar-24-26 11:03AM
Mar-23-26 07:00AM
Mar-16-26 12:27AM
Mar-12-26 09:00AM
Mar-03-26 08:18AM
Mar-01-26 11:35AM
Feb-26-26 04:34PM
04:06PM
Loading…
04:06PM
(Investor's Business Daily)
11:21AM
10:17AM
08:30AM
07:55AM
07:04AM
02:11AM
12:04AM
Feb-25-26 07:25PM
04:02PM
Feb-24-26 10:20AM
Feb-23-26 04:03PM
07:23AM
Feb-12-26 08:09AM
Feb-05-26 08:15AM
05:40PM
Loading…
Feb-04-26 05:40PM
04:03PM
Jan-26-26 04:03PM
Jan-08-26 09:12AM
Jan-07-26 08:41AM
Dec-22-25 06:50AM
Dec-15-25 07:03AM
Nov-20-25 04:03PM
Nov-18-25 05:07AM
Nov-05-25 12:04AM
Nov-04-25 05:40PM
04:03PM
Oct-30-25 10:00AM
Oct-29-25 09:00AM
Oct-28-25 10:00AM
Oct-20-25 11:08PM
09:20AM
Oct-15-25 04:03PM
Sep-15-25 09:01AM
Sep-04-25 06:13AM
Aug-27-25 08:29AM
Aug-21-25 12:30PM
11:15AM
Aug-13-25 12:08PM
Aug-06-25 05:45PM
04:03PM
Aug-05-25 08:15AM
Aug-04-25 05:45PM
Jul-31-25 10:30AM
Jul-30-25 10:00AM
Jul-25-25 07:00AM
Jul-24-25 06:00PM
Jul-23-25 08:00AM
Jul-21-25 04:03PM
Jul-14-25 09:15PM
Apr-29-25 04:03PM
Apr-24-25 04:03PM
02:37PM
08:15AM
07:00AM
Apr-10-25 04:03PM
Mar-29-25 06:03PM
Mar-24-25 08:00AM
Mar-20-25 09:05AM
Mar-14-25 08:00AM
Feb-26-25 09:32AM
(Thomson Reuters StreetEvents)
+8.61%
02:15AM
Feb-25-25 05:25PM
04:02PM
01:22AM
Feb-13-25 02:10PM
Feb-07-25 08:00AM
Jan-16-25 12:00PM
Dec-28-24 04:59AM
Nov-29-24 11:15AM
Nov-26-24 04:05PM
Nov-07-24 12:00PM
Nov-01-24 02:27PM
(Investor's Business Daily)
Oct-29-24 08:43PM
12:00PM
11:56AM
(Investor's Business Daily)
03:03AM
Oct-28-24 05:41PM
(Investor's Business Daily)
+32.33%
04:19PM
02:17PM
11:39AM
08:10AM
07:00AM
07:00AM
Oct-25-24 09:35AM
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.
President Mr. Larry L. Wood
Executive VP & CFO Mr. Kevin Waters
EVP Ms. Alaleh Nouri
Executive Vice President of Operations Mr. Christofer Christoforou
Executive VP & CTO Mr. Barry Templin
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Nouri Alaleh EVP, CLO, CORP. SEC. Mar 19 '26 Sale 25.96 5,363 139,231 105,354 Mar 19 05:47 PM Alalah Nouri Officer Mar 19 '26 Proposed Sale 26.17 5,363 140,349 Mar 19 04:57 PM Nouri Alaleh EVP, CLO, CORP. SEC. Mar 17 '26 Sale 28.15 304 8,559 110,717 Mar 19 04:25 PM Waters Kevin EVP, CFO Mar 17 '26 Sale 28.15 706 19,876 151,558 Mar 19 04:25 PM Nouri Alaleh Officer Mar 17 '26 Proposed Sale 28.15 304 8,559 Mar 17 03:14 PM Waters Kevin Officer Mar 17 '26 Proposed Sale 28.15 706 19,876 Mar 17 03:13 PM Nouri Alaleh EVP, CLO, CORP. SEC. Mar 10 '26 Sale 25.65 3,243 83,197 111,021 Mar 12 04:02 PM Alalah Nouri Officer Mar 10 '26 Proposed Sale 25.26 3,243 81,918 Mar 10 04:04 PM Desai Antal Rohit Director Mar 05 '26 Buy 25.58 167,246 4,278,549 167,246 Mar 09 07:19 PM Desai Antal Rohit Director Mar 06 '26 Buy 23.59 160,317 3,781,503 327,563 Mar 09 07:19 PM Desai Antal Rohit Director Mar 09 '26 Buy 24.55 98,699 2,422,891 426,262 Mar 09 07:19 PM Nouri Alaleh EVP, CLO, CORP. SEC. Mar 06 '26 Sale 23.70 6,892 163,353 114,264 Mar 09 05:43 PM Waters Kevin EVP, CFO Mar 06 '26 Sale 23.70 6,721 159,300 152,264 Mar 09 05:40 PM Nouri Alaleh Officer Mar 06 '26 Proposed Sale 23.70 6,892 163,353 Mar 06 04:19 PM Waters Kevin Officer Mar 06 '26 Proposed Sale 23.70 6,721 159,300 Mar 06 04:07 PM Desai Antal Rohit Director Aug 14 '25 Option Exercise 1.33 26,749 35,576 35,152 Aug 15 04:53 PM MOLL FREDERIC H Director Aug 13 '25 Buy 39.26 20,000 785,138 863,159 Aug 14 04:18 PM Nouri Alaleh EVP, CLO, CORP. SEC. Aug 14 '25 Option Exercise 4.52 11,000 49,720 72,473 Aug 14 04:15 PM Desai Antal Rohit Director Jun 10 '25 Sale 63.91 25,000 1,597,711 64,363 Jun 12 07:28 PM Desai Antal Rohit Director Jun 11 '25 Sale 63.38 25,000 1,584,525 39,363 Jun 12 07:28 PM Desai Antal Rohit Director Jun 12 '25 Sale 61.49 25,000 1,537,256 14,363 Jun 12 07:28 PM
